telmisartan has been researched along with Hyperglycemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, DH | 1 |
| Abo-Youssef, AM; Khallaf, WA; Khattab, MM; Messiha, BAS | 1 |
| Bae, SJ; Chang, J; Cho, DH; Cho, KW; Jo, I; Park, JH; Song, KH | 1 |
| Cho, DH; Jo, I; Kim, SA; Park, JH; Park, JY; Seo, J; Song, KH | 1 |
| Arita, M; Furuta, M; Sanke, T; Shimajiri, Y; Yamana, A | 1 |
| Fukuoka, N; Inoue, T; Kikumoto, Y; Kitagawa, M; Maeshima, Y; Makino, H; Masuoka, N; Morinaga, H; Ogino, K; Saeki, M; Sugiyama, H; Takiue, K; Wang, DH | 1 |
| Limor, R; Oron, Y; Rosenthal, T; Stern, N; Younis, F; Zangen, S | 1 |
| Poolsup, N; Prasit, T; Suksomboon, N | 1 |
| Fujishima, H; Fujita, H; Hosoba, M; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, K; Takahashi, T; Yamada, Y | 1 |
| Hamamoto, Y; Honjo, S; Koshiyama, H; Nichi, Y; Wada, Y | 1 |
| Anderson, C; Gerstein, HC; Held, C; Hilbrich, L; Sleight, P; Teo, K; Yusuf, S; Zhao, F | 1 |
| Ceriello, A; Esposito, K; Giugliano, D; Piconi, L | 1 |
| Audeval-Gerard, C; Champeroux, P; Richard, S; Wienen, W | 1 |
1 review(s) available for telmisartan and Hyperglycemia
| Article | Year |
|---|---|
Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
Topics: Adiponectin; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hyperglycemia; Hyperinsulinism; Hypertension; Insulin Resistance; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2012 |
3 trial(s) available for telmisartan and Hyperglycemia
| Article | Year |
|---|---|
The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertension; Insulin Resistance; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Possible beneficial effect of telmisartan on glycemic control in diabetic subjects.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Male; Telmisartan | 2005 |
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Complications; Drug Therapy, Combination; Fasting; Female; Heart Failure; Hospitalization; Humans; Hyperglycemia; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Ramipril; Risk Factors; Telmisartan | 2007 |
10 other study(ies) available for telmisartan and Hyperglycemia
| Article | Year |
|---|---|
Telmisartan Inhibits Nitric Oxide Production and Vessel Relaxation via Protein Phosphatase 2A-mediated Endothelial NO Synthase-Ser
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Cattle; Disease Models, Animal; Endothelium, Vascular; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Phosphorylation; Protein Phosphatase 2; Protein Phosphatase 2C; Rats; Serine; Telmisartan | 2019 |
The anti-Alzheimer effect of telmisartan in a hyperglycemic ovariectomized rat model; role of central angiotensin and estrogen receptors.
Topics: Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Blood-Brain Barrier; Female; Hyperglycemia; Models, Animal; Ovariectomy; Rats; Rats, Wistar; Receptors, Estrogen; Telmisartan | 2020 |
Telmisartan mitigates hyperglycemia-induced vascular inflammation by increasing GSK3β-Ser
Topics: Animals; Aorta; Benzimidazoles; Benzoates; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Glycogen Synthase Kinase 3 beta; Hyperglycemia; Inflammation; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Phosphoserine; Structure-Activity Relationship; Telmisartan; Vasculitis | 2017 |
Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cattle; Cell Adhesion; Diabetes Mellitus; Endothelial Cells; Humans; Hyperglycemia; I-kappa B Kinase; Inflammation; Monocytes; PPAR gamma; Rosiglitazone; Telmisartan; Thiazolidinediones; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice.
Topics: Acatalasia; Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Glucose; Body Weight; Catalase; Cell Death; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Homozygote; Hyperglycemia; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mice, Mutant Strains; Superoxide Dismutase; Telmisartan | 2010 |
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hyperglycemia; Hypertension; Insulin; Insulin Resistance; Leptin; PPAR gamma; Rats; Rats, Inbred SHR; Rosiglitazone; Telmisartan; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain | 2010 |
Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
Topics: Acetophenones; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Chemical Analysis; Blood Glucose; Blotting, Western; Diabetes Mellitus; Diabetic Nephropathies; Dinoprostone; Enzyme Inhibitors; Hyperglycemia; Immunohistochemistry; Kidney; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; NF-E2-Related Factor 2; Superoxide Dismutase; Superoxides; Telmisartan | 2012 |
[Revised blood pressure goals and no elevated glucose readings in between].
Topics: Acarbose; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Postprandial Period; Risk Factors; Telmisartan | 2005 |
Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Antioxidants; Ascorbic Acid; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Endothelium, Vascular; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Telmisartan; Vascular Diseases | 2007 |
Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hyperglycemia; Hypertension; Kidney; Kidney Glomerulus; Lisinopril; Male; Organ Size; Proteinuria; Rats; Rats, Inbred SHR; Reference Values; Telmisartan | 2001 |